Report: impact of inflammatory bowel disease.
Inflammatory bowel disease (IBD) includes ulcerative colitis (UC) and Crohn's disease (CD), 2 conditions characterized by chronic inflammation. Approximately 1.17 million people in the United States are affected by these 2 conditions. It is theorized that a genetic susceptibility coupled with environmental factors, such as smoking, antibiotics, oral contraceptives, appendectomy, or diet, may influence the development of IBD. Patients with UC and CD may exhibit similar symptoms, and the conditions are often misclassified, as there is a lack of standard criteria for diagnosing IBD. Therefore, it is important for clinicians to rule out any diarrhea-related conditions for an accurate diagnosis. UC and CD typically manifest in early adulthood, and the chronic nature of these conditions greatly impacts a patient's perception, body image, and quality of life. The inability to participate in social activities due to UC and CD impacts not only patients, but also those with whom they have close relationships.
Sheila M
SM
Wilhelm
D000900:Anti-Bacterial Agents / Q000009:adverse effects; D001062:Appendectomy; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D004032:Diet; D020022:Genetic Predisposition to Disease; D017048:Health Care Costs; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000175:diagnosis / Q000191:economics / Q000453:epidemiology* / Q000209:etiology; D011788:Quality of Life; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents; D003278:Contraceptives, Oral, Hormonal